Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Retained Earnings (2016 - 2026)

Cytosorbents filings provide 16 years of Retained Earnings readings, the most recent being -$312.2 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 2.7% to -$312.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$312.2 million, a 2.7% decrease, with the full-year FY2025 number at -$312.2 million, down 2.7% from a year prior.
  • Retained Earnings hit -$312.2 million in Q4 2025 for Cytosorbents, down from -$3.8 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $2.3 million in Q4 2022 to a low of -$312.2 million in Q4 2025.
  • Median Retained Earnings over the past 5 years was -$247.1 million (2022), compared with a mean of -$177.0 million.
  • Biggest five-year swings in Retained Earnings: skyrocketed 358.27% in 2022 and later crashed 57533.77% in 2024.
  • Cytosorbents' Retained Earnings stood at -$221.2 million in 2021, then skyrocketed by 101.05% to $2.3 million in 2022, then plummeted by 77.27% to $529321.0 in 2023, then crashed by 57533.77% to -$304.0 million in 2024, then fell by 2.7% to -$312.2 million in 2025.
  • The last three reported values for Retained Earnings were -$312.2 million (Q4 2025), -$3.8 million (Q3 2025), and -$4.0 million (Q2 2025) per Business Quant data.